How New Science is Reshaping Ovarian Cancer Treatment and Care
Ovarian cancer is often diagnosed at an advanced stage, but research is reshaping how scientists understand and treat the...
Tag: AACR D3 2026
Ovarian cancer is often diagnosed at an advanced stage, but research is reshaping how scientists understand and treat the...
Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New...
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next...
During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology...